陽光100中國(02608.HK)更換核數師
陽光100中國(02608.HK)公布,畢馬威已辭任公司核數師,自上周六(7日)起生效。公司委任中審眾環為核數師以填補畢馬威辭任後之臨時空缺,任期直至公司下屆股東周年大會結束為止。
畢馬威於其信函中表示,在其對集團截至去年12月底止年度之綜合財務報表進行審計相關的風險評估中,畢馬威確定了一些需要解釋及/或支持文件的事項。該些事項關於來自指定主體的應收款、逾期借款、債券違約、交叉違約及公司持續經營能力的重大不確定性。集團管理層尚未提供所要求的資料、解釋及/或相關支持文件,截止辭任日期,該等事項仍未解決。因此,畢馬威無法進一步對集團截至去年度之綜合財務報表進行審核。
公司股份自4月1日起停牌,並將續停牌直至另行通知。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.